Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Opdivdo
Opdivdo
Just-Announced U.S. and Cuba Biopharma Venture Sees Fruit in Lung Cancer Study
BioSpace
Thu, 09/27/18 - 11:09 pm
Cuba
Bristol-Myers Squibb
Opdivdo
lung cancer
Opdivo Approved in Europe for Additional Use in Melanoma Patients
CP Wire
Tue, 07/31/18 - 10:12 am
Opdivdo
Bristol-Myers Squibb
melanoma
advanced melanoma
Europe
Opdivo Approved in Europe for Additional Use in Melanoma Patients
Tue, 07/31/18 - 09:29 am
Opdivdo
Bristol-Myers Squibb
melanoma
advanced melanoma
Opdivo Gains New Approval in Combination with Yervoy
Wed, 07/11/18 - 10:11 am
Bristol-Myers Squibb
Opdivdo
metastatic colorectal cancer
Nektar Therapeutics (NKTR) Has Jumped To A New High On Study Results
NASDAQ.com
Mon, 11/13/17 - 10:54 am
Nektar
NKTR-214
Opdivdo
Bristol-Myers Squibb